Welcome! Login | Register
 

Worcester Man Arrested After Assaulting and Kidnapping Girlfriend—Worcester Man Arrested After Assaulting and Kidnapping Girlfriend

Man Stabbed Outside of 3 G’s Bar on Millbury Street in Worcester—Man Stabbed Outside of 3 G's Bar on…

Patriots Ranked as 2nd Most Unlikable Team in NFL—Patriots Ranked as 2nd Most Unlikable Team in…

Worcester Man Tied to Road Rage Stabbing Arrested—Worcester Man Tied to Road Rage Stabbing Arrested

Worcester Man Was Intended Victim of Freemont Street Shooting—Worcester Man Was Intended Victim of Freemont Street…

President Reagan Shooter Hinckley Jr. to be Released to Home Stay—President Reagan Shooter Hinckley Jr. to be Released…

Clinton Cements Position as Democratic Presidential Nominee—Clinton Cements Position as Democratic Presidential Nominee

UMass Memorial - Marlborough Hospital Announces New Prostate Cancer Detection Technology—UMass Memorial - Marlborough Hospital Announces New Prostate…

10 Don’t Miss Acts at 2016 Newport Jazz—10 Don't Miss Acts at 2016 Newport Jazz

Chef Walter’s Flavors + Knowledge: Couscous With Spicy Seafood—Chef Walter's Flavors + Knowledge: Couscous With Spicy…

 
 

AG Announces $68.5 Million Settlement with AstraZeneca

Friday, March 11, 2011

 

Attorney General Peter Kilmartin announced today that a $68.5 million dollar settlement has been reached with AstraZeneca Pharmaceuticals.

This settlement, which is the largest ever multi-state consumer protection-based pharmaceutical settlement, is expected to bring $908,838 to the state.

The settlement stems from a complaint alleging that AstraZeneca used deceptive practices to market the antipsychotic drug Seroquel for off-label uses, according to the Attorney General. The company was accused of withholding information on the drug’s dangerous potential side effects, in addition to the negative results of scientific study done that tested the safety of the drug.

“This settlement shows the commitment of this office to protect consumers from deceptive marketing and advertising practices by big pharmaceutical companies,” Kilmartin said.

Company promises changes

AstraZeneca has promised to alter the way that it markets Seroquel, eliminating the misleading practices in question. Along with the $68.5 million payment, under the settlement AstraZeneca must comply with provisions addressing numerous concerns that an extensive 3-year investigation yielded. For example, AstraZeneca must have policies in place to ensure that sales personnel do not promote to health care providers who are unlikely to prescribe Seroquel for an FDA-approved use.

Other states participating in the investigation and settlement were: Florida, Illinois, Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Idaho, Iowa, Kansas, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Vermont, Washington, West Virginia and Wisconsin.
 

 

Enjoy this post? Share it with others.